LEP and obesity due to melanocortin 4 receptor deficiency: Neonatal treatment with leptin, from P3 to P13, can also reduce the hyperleptinemia, hyperinsulinemia, hyperphagia, and obesity associated with in utero growth restriction and subsequent high fat diet, albeit with some sex differences (Vickers et al., 2005, 2008).